Pain After Proximal Digital Amputation Prevention : Pain After Proximal Digital Amputation Prevention
Patients who require proximal amputations will have the opportunity to enroll in the study, will be randomized intraoperatively to receiving one of the aforementioned treatments, and will be followed at 3 and 6 month for outcome measures..
| Medienart: |
|
|---|
Klinische Studie| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
ClinicalTrials.gov - (2023) vom: 30. Aug. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
610 |
|---|
| Anmerkungen: |
Source: Link to the current ClinicalTrials.gov record., First posted: May 7, 2020, Last downloaded: ClinicalTrials.gov processed this data on September 06, 2023, Last updated: September 06, 2023 |
|---|
| Study ID: |
NCT04378062 |
|---|---|
| Veröffentlichungen zur Studie: |
|
| fisyears: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
CTG00338389X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | CTG00338389X | ||
| 003 | DE-627 | ||
| 005 | 20230906010403.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210408s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)CTG00338389X | ||
| 035 | |a (UBBS_Klinische_Studien)NCT04378062 | ||
| 035 | |a (UBBS_Klinische_Studien)1907889836 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a Pain After Proximal Digital Amputation Prevention |b Pain After Proximal Digital Amputation Prevention |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: Link to the current ClinicalTrials.gov record., First posted: May 7, 2020, Last downloaded: ClinicalTrials.gov processed this data on September 06, 2023, Last updated: September 06, 2023 | ||
| 520 | |a Patients who require proximal amputations will have the opportunity to enroll in the study, will be randomized intraoperatively to receiving one of the aforementioned treatments, and will be followed at 3 and 6 month for outcome measures. | ||
| 650 | 2 | |a Neuroma | |
| 650 | 4 | |a Study Type: Interventional | |
| 650 | 4 | |a Recruitment Status: Terminated | |
| 650 | 4 | |a 610 | |
| 773 | 0 | 8 | |i Enthalten in |t ClinicalTrials.gov |g (2023) vom: 30. Aug. |
| 773 | 1 | 8 | |g year:2023 |g day:30 |g month:08 |
| 856 | 4 | 0 | |u https://clinicaltrials.gov/show/NCT04378062 |z kostenfrei |3 Volltext |
| 912 | |a GBV_CTG | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 30 |c 08 | ||